As of January 2026 Kiniksa Pharmaceuticals has a market cap of $2.87 Billion USD. This makes Kiniksa Pharmaceuticals the world's 4079th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 15th, 2026 the market cap of Kiniksa Pharmaceuticals was reported to be: